Insights

insight-blog-image
July 31, 2025
Healthcare M&A Weekly 7.31.25

A Look at Recent Transactions Shaping the Future of Healthcare

The healthcare industry is rapidly evolving, with the lines between the healthcare technology and services sectors blurring - creating the catalyst for innovation, transformation, and continued market activity. TripleTree's Healthcare M&A Weekly summarizes recent mergers, acquisitions, and investments shaping the future of healthcare.

To view previous healthcare M&A activity, please review the last post: Healthcare M&A Weekly - July 8, 2025.

AbsoluteCare secured $135 million in equity financing through a strategic investment from Kinderhook Industries, CVS Health Ventures, Pacific Life, and Lexington Partners. Read more about the investment here.

Avalyn completed an oversubscribed $100 Million Series D financing to further advance clinical development of novel inhaled therapies for Pulmonary Fibrosis. The round was co-led by Suvretta Capital Management and SR One, with participation from 16 other healthcare investors. View more about the financing here.

BetterRX, a hospice pharmacy platform, has received a strategic growth investment from BVP Forge. Learn more about the investment here.

BRM Specialty Markets, a medical stop-loss managing general underwriter, has been acquired by Sands Point Risk. Read more about the acquisition here.

Community Health Systems, (NYSE: CYH) announced that its subsidiary, CHS/Community Health Systems, Inc. (CHS), has entered into a definitive agreement with Labcorp (NYSE: LH), pursuant to which Labcorp will acquire select assets and assume certain leases of the ambulatory outreach laboratory services of CHS health systems in 13 states, including certain patient service centers and in-office phlebotomy locations, for $195 million cash. View the announcement here.

Cooler Heads, a medical device company, closed an oversubscribed $11 million Series A funding round led by Mutual Capital Partners. Read the press release here.

Dispatch Bio launched with $216 million in Series A funding to develop a universal treatment for solid tumors using its novel Flare platform. The Series A syndicate includes founding investors ARCH Venture Partners and PICI, along with Bristol Myers Squibb, the University of Pennsylvania, Stanford University, and Alexandria Venture InvestmentsLearn more here.

Family Health Services has been acquired by Crossroads Treatment Centers, a provider of medication-assisted treatment (MAT) for substance use disorder, expanding its services in Pennsylvania with locations in New Kensington and Ford City. Read more about the acquisition here.

Fortuna Health raised $18M in Series A funding led by Andreessen Horowitz to modernize Medicaid access and infrastructure amid federal reforms. View the announcement here.

Hemanext Inc., an innovator in blood processing, storage, and transfusion technology, has successfully closed its Series B-3 equity financing round. The round secured $18.9 million at a post-money valuation of $172 million, with contributions from both new and returning investors. Read the press release here.

Iodine Software, a healthcare AI company specializing in clinical documentation improvement and revenue cycle, will be acquired by Waystar from Advent International for a total enterprise value of $1.25B. Learn more about the acquisition here.

iTeos Therapeutics entered into an agreement to be acquired by Concentra Biosciences for $475 million plus a Contingent Value Right. View more about the acquisition here.

New York’s Medical Research Network, a U.S.-based clinical research site located in New York City, specializing in psychiatry and neurology trials focused on central nervous system (CNS) disorders, has been acquired by The IMA GroupRead more about the acquisition here.

Novaestiq Corp. and the U.S. rights to the injectable hyaluronic acid gel line Saypha have been acquired by Waldencast under the Obagi Medical brand. View the announcement here.

PharmChem, a provider of sweat patches to detect drugs of abuse, was acquired by Alcohol Monitoring Systems.  Learn more about the acquisition here.

SoldierPoint Digital Health, LLC is set to be acquired by GovCIO, a Welsh, Carson, Anderson & Stowe company. SoldierPoint specializes in digital health solutions for Veterans, and this acquisition includes SoldierPoint's seven-year, $2 billion Connected Care Integrated Network (CCIN) contract with the Department of Veterans Affairs (VA). Read the press release here.

Transcend Imaging, a provider of mobile MR imaging labs, received a strategic growth investment from Modular Devices, a provider of mobile and modular medical imaging equipment labs. Learn more here.

ZimVie announced a definitive agreement to be acquired by ARCHIMED for $19.00 per share in cash, for a total enterprise value of approximately $730 million. ZimVie (Nasdaq: ZIMV) is a global life sciences leader in the dental implant market. View the announcement here.

Transactions outlined in this summary highlight some of the key trends shaping the future of healthcare. Get the latest industry news from TripleTree every week.

This is a partial list of transaction activity across the healthcare industry and is not intended to be a complete listing. Transaction information was identified from various sources and TripleTree may or may not have acted as the financial advisor for the transactions listed. All product names, logos and brands are property of their respective owners. All company, product and service names used in this communication are for identification purposes only. Use of these names, logos and brands does not imply endorsement.

SHARE ON

TAGS